Literature DB >> 23312985

Quadriceps weakness contributes to exercise capacity in nonspecific interstitial pneumonia.

Fumiko Watanabe1, Hiroyuki Taniguchi, Koji Sakamoto, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Shinichi Arizono, Osamu Nishiyama, Yoshinori Hasegawa.   

Abstract

BACKGROUND AND
OBJECTIVE: It has been shown that peripheral muscle dysfunction is a critical factor in determining exercise intolerance in patients with several chronic lung diseases, including idiopathic pulmonary fibrosis. We hypothesized that exercise capacity would be, at least in part, determined by peripheral muscle dysfunction in patients with fibrotic nonspecific interstitial pneumonia (f-NSIP), another major subtype of fibrotic interstitial lung disease. The aim of the current study was to elucidate the relevance of peripheral muscle dysfunction and its contribution to exercise intolerance in f-NSIP.
METHODS: The six-minute walk test was evaluated in 30 consecutive patients with f-NSIP along with potential determinants of exercise capacity, including respiratory muscle force and peripheral muscle force.
RESULTS: Among 30 patients, the median age was 61 years, and 21 were female. Sixteen patients showed significantly decreased quadriceps force (QF), and 17 had significant decreases in maximum expiratory pressure. Exercise capacity and muscle power were clearly related to sex. Adjusted for sex, QF showed a significant relation to exercise capacity measured by six-minute walk distance (6MWD), whereas pulmonary function parameters such as vital capacity showed marginal correlations. In stepwise multiple regression analysis, only QF was an independent predictor of 6MWD.
CONCLUSIONS: Quadriceps weakness is often observed in patients with f-NSIP. It seems that QF significantly contributes to exercise capacity in this population.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312985     DOI: 10.1016/j.rmed.2012.12.013

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

Review 1.  Respiratory and lower limb muscle function in interstitial lung disease.

Authors:  Marios Panagiotou; Vlasis Polychronopoulos; Charlie Strange
Journal:  Chron Respir Dis       Date:  2016-01-14       Impact factor: 2.444

2.  Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: comparison with chronic obstructive pulmonary disease.

Authors:  Shinichi Arizono; Hiroyuki Taniguchi; Koji Sakamoto; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Tomoya Ogawa; Fumiko Watanabe; Kazuyuki Tabira; Ryo Kozu
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Impact of Psychological Deficits and Pain on Physical Activity of Patients with Interstitial Lung Disease.

Authors:  Seo Am Hur; Sabina A Guler; Nasreen Khalil; Pat G Camp; Jordan A Guenette; Christopher J Ryerson
Journal:  Lung       Date:  2019-06-01       Impact factor: 2.584

4.  Effects of different exercise training programs on the functional performance in fibrosing interstitial lung diseases: A randomized trial.

Authors:  Hatem Essam; Nashwa Hassan Abdel Wahab; Gihan Younis; Enas El-Sayed; Hanaa Shafiek
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

5.  Functional clinical impairments and frailty in interstitial lung disease patients.

Authors:  Pierre-François Tremblay Labrecque; Geneviève Dion; Didier Saey
Journal:  ERJ Open Res       Date:  2022-10-17

6.  Identifying decreased diaphragmatic mobility and diaphragm thickening in interstitial lung disease: the utility of ultrasound imaging.

Authors:  Pauliane Vieira Santana; Elena Prina; André Luis Pereira Albuquerque; Carlos Roberto Ribeiro Carvalho; Pedro Caruso
Journal:  J Bras Pneumol       Date:  2016-04       Impact factor: 2.624

7.  Relationship of pectoralis muscle area and skeletal muscle strength with exercise tolerance and dyspnea in interstitial lung disease.

Authors:  Krauspenhar Merola Pietro; Gass Ricardo; Gustavo Paulus Nenê Dorneles Rui; Basso Gazzana Marcelo; Ferreira Gazzoni Fernando; Hochhegger Bruno; Verges Samuel; C Berton Danilo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

8.  Skeletal muscle oxygenation and regional blood volume during incremental limb loading in interstitial lung disease.

Authors:  Lisa Wickerson; Sunita Mathur; Dina Brooks; L V Bonetti; Lianne G Singer; John Granton; W Darlene Reid
Journal:  ERJ Open Res       Date:  2020-01-27

9.  Factors influencing self-selected walking speed in fibrotic interstitial lung disease.

Authors:  Gabriela Fischer; Francisco B de Queiroz; Danilo C Berton; Pedro Schons; Henrique B Oliveira; Marcelo Coertjens; Mathieu Gruet; Leonardo A Peyré-Tartaruga
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

10.  The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial.

Authors:  Atsushi Suzuki; Masahiko Ando; Tomoki Kimura; Kensuke Kataoka; Toshiki Yokoyama; Eiichi Shiroshita; Yasuhiro Kondoh
Journal:  BMC Pulm Med       Date:  2020-02-24       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.